Pharma ambivalent on health reform; Academia-pharma embrace hard to break;

> Will pharma actually throw its weight behind health reform, as it has promised of late? A recent editorial in the Wall Street Journal suggests "maybe not." FiercePharma

> In theory, it's possible to extract academia from the embrace of pharma over time. But in all practicality, it's going to be challenging--at best--to actually make it happen. FiercePharma

> World Health Organization officials met with the world's top vaccine suppliers this week to discuss whether to create a global stockpile of swine flu vaccine. FierceVaccines

> How should you deal with the "alpha doc," the tightly-wound, Ivy League-school achiever used to getting his way? Dr. Kenneth Cohn has some suggestions. Hospital Impact

And Finally... Won't someone think of the children? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.